Corbus Pharmaceuticals received a fast-track designation from the Food and Drug Administration for its treatment of relapsed or refractory metastatic cervical cancer.
Cancer is a relentless disease that knows no boundaries. It affects people of all ages and backgrounds, making it one of the world's leading causes of death.